Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Detection of microcirculatory impairment by transcutaneous oxymetry monitoring during hemodialysis: an observational study

Authors: Ygal Benhamou, Loic Begarin, Nathalie David, Nicole Cailleux, Catherine Bessin, Herve Lévesque, Stephane Edet

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Little is known about the effects of intermittent hemodialysis on microcirculatory perfusion. The aim of this study is to assess the effects of hemodialysis on microvascular perfusion using transcutaneous oxymetry (TCPO2).

Methods

In this observational study, hourly TCPO2 measurements were performed during hemodialysis sessions. Ankle brachial index (ABI) was carried out to classify patients according their vascular condition.

Results

50 patients (mean age 70 ± 8 years old) were enrolled. Mean TCPO2 decreased significantly on average 23.9% between start and finish of hemodialysis. Severe ischemia (TCPO2 < 30 mmHg) and critical ischemia (TCPO2 < 10 mmHg) occurred during dialysis in 47.1% and 15.5% respectively. Critical ischemia occurred only in limbs with ABI < 0.9 (8.3%) or > 1.3 (28%). Patients with critical ischemia experienced a significantly larger decline in mean blood pressure (32.4 ± 26.1 mmHg vs 12.7 ± 10.7 mmHg; P = 0.007) and a more pronounced ultrafiltration (45.55 ± 16.9 ml/kg vs 35.17 ± 18.2 ml/kg; P = 0.04) compared to patients without ischemia. Clinical outcomes (death or vascular procedures) were five times more frequent in patients who had developed critical ischemia (55.7% vs 10.1% P = 0.01). The elevated age of patients, the low basal value of TCPO2, and the occurrence of critical ischemia were more frequently associated with clinical outcome (P = 0.03, P = 0.048, P = 0.01 respectively).

Conclusions

This study demonstrates that hemodialysis induces microcirculatory injury, dependent on blood pressure reduction, peripheral vascular state and ultrafiltration. The occurrence of critical ischemia is associated to pejorative patient outcome and therefore, TCPO2 seems to be useful to avoid potential distal tissue damage during hemodialysis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R: Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006, 114: 1914-1922. 10.1161/CIRCULATIONAHA.105.607390.CrossRefPubMed Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R: Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006, 114: 1914-1922. 10.1161/CIRCULATIONAHA.105.607390.CrossRefPubMed
2.
go back to reference O’Hare AM, Glidden DV, Fox CS, Hsu CY: High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2004, 109: 320-323. 10.1161/01.CIR.0000114519.75433.DD.CrossRefPubMed O’Hare AM, Glidden DV, Fox CS, Hsu CY: High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2004, 109: 320-323. 10.1161/01.CIR.0000114519.75433.DD.CrossRefPubMed
3.
go back to reference Collins AJ: Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003, 325: 163-167. 10.1097/00000441-200304000-00002.CrossRefPubMed Collins AJ: Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003, 325: 163-167. 10.1097/00000441-200304000-00002.CrossRefPubMed
4.
go back to reference Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007, 33 (Suppl 1): S1-S75.CrossRefPubMed Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007, 33 (Suppl 1): S1-S75.CrossRefPubMed
5.
go back to reference Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006, 4: 566-573. 10.1111/j.1538-7836.2005.01780.x.CrossRefPubMed Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006, 4: 566-573. 10.1111/j.1538-7836.2005.01780.x.CrossRefPubMed
6.
go back to reference Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007, 116: 85-97. 10.1161/CIRCULATIONAHA.106.678342.CrossRefPubMed Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007, 116: 85-97. 10.1161/CIRCULATIONAHA.106.678342.CrossRefPubMed
7.
go back to reference Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the hoorn study. J Am Soc Nephrol. 2006, 17: 537-545. 10.1681/ASN.2005080834.CrossRefPubMed Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the hoorn study. J Am Soc Nephrol. 2006, 17: 537-545. 10.1681/ASN.2005080834.CrossRefPubMed
8.
go back to reference Eggers PW, Gohdes D, Pugh J: Nontraumatic lower extremity amputations in the medicare end-stage renal disease population. Kidney Int. 1999, 56: 1524-1533. 10.1046/j.1523-1755.1999.00668.x.CrossRefPubMed Eggers PW, Gohdes D, Pugh J: Nontraumatic lower extremity amputations in the medicare end-stage renal disease population. Kidney Int. 1999, 56: 1524-1533. 10.1046/j.1523-1755.1999.00668.x.CrossRefPubMed
9.
go back to reference Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G: Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care. 1999, 22: 147-151. 10.2337/diacare.22.1.147.CrossRefPubMed Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G: Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care. 1999, 22: 147-151. 10.2337/diacare.22.1.147.CrossRefPubMed
10.
go back to reference Zimny S, Dessel F, Ehren M, Pfohl M, Schatz H: Early detection of microcirculatory impairment in diabetic patients with foot at risk. Diabetes Care. 2001, 24: 1810-1814. 10.2337/diacare.24.10.1810.CrossRefPubMed Zimny S, Dessel F, Ehren M, Pfohl M, Schatz H: Early detection of microcirculatory impairment in diabetic patients with foot at risk. Diabetes Care. 2001, 24: 1810-1814. 10.2337/diacare.24.10.1810.CrossRefPubMed
11.
go back to reference Becker F, Loppinet A: Chronic critical ischemia of the legs. Definition and management. Ann Cardiol Angeiol (Paris). 2007, 56: 63-69. 10.1016/j.ancard.2006.09.007.CrossRef Becker F, Loppinet A: Chronic critical ischemia of the legs. Definition and management. Ann Cardiol Angeiol (Paris). 2007, 56: 63-69. 10.1016/j.ancard.2006.09.007.CrossRef
12.
go back to reference Sato M, Morita H, Ema H, Yamaguchi S, Amano I: Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis. Clin Nephro. 2006, 66: 426-432. 10.5414/CNP66426.CrossRef Sato M, Morita H, Ema H, Yamaguchi S, Amano I: Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis. Clin Nephro. 2006, 66: 426-432. 10.5414/CNP66426.CrossRef
13.
go back to reference Benhamou Y, Edet S, Begarin L, Cailleux N, Hanoy M, Bessin C, Godin M, Levesque H: Transcutaneous oxymetry as predictive test of peripheral vascular revascularization in haemodialysis population. Nephrol Dial Transplant. 2011, 27: 2066-2069.CrossRefPubMed Benhamou Y, Edet S, Begarin L, Cailleux N, Hanoy M, Bessin C, Godin M, Levesque H: Transcutaneous oxymetry as predictive test of peripheral vascular revascularization in haemodialysis population. Nephrol Dial Transplant. 2011, 27: 2066-2069.CrossRefPubMed
14.
go back to reference Santesson P, Danielsson A, Iseda I, Adamson U, Lins PE, Jorneskog G: Impaired peripheral micro- and macrocirculation during hemodialysis in uremic patients. Int Angiol. 2010, 29: 362-370.PubMed Santesson P, Danielsson A, Iseda I, Adamson U, Lins PE, Jorneskog G: Impaired peripheral micro- and macrocirculation during hemodialysis in uremic patients. Int Angiol. 2010, 29: 362-370.PubMed
15.
go back to reference Got I: Transcutaneous oxygen pressure (TcPO2): advantages and limitations. Diabetes Metab. 1998, 24: 379-384.PubMed Got I: Transcutaneous oxygen pressure (TcPO2): advantages and limitations. Diabetes Metab. 1998, 24: 379-384.PubMed
16.
go back to reference Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006, 113: e463-e654.CrossRefPubMed Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006, 113: e463-e654.CrossRefPubMed
17.
go back to reference Ladurner R, Kuper M, Konigsrainer I, Lob S, Wichmann D, Konigsrainer A, Coerper S, Beckert S: Predictive value of routine transcutaneous tissue oxygen tension (tcpO2) measurement for the risk of non-healing and amputation in diabetic foot ulcer patients with non-palpable pedal pulses. Med Sci Monit. 2010, 16: CR273-CR277.PubMed Ladurner R, Kuper M, Konigsrainer I, Lob S, Wichmann D, Konigsrainer A, Coerper S, Beckert S: Predictive value of routine transcutaneous tissue oxygen tension (tcpO2) measurement for the risk of non-healing and amputation in diabetic foot ulcer patients with non-palpable pedal pulses. Med Sci Monit. 2010, 16: CR273-CR277.PubMed
18.
go back to reference Mistrik E, Dusilova Sulkova S, Blaha V, Kalousova M, Knizek J, Moucka P, Herout V, Kadlec M, Stilec R, Sobotka L: Evaluation of skin microcirculation during hemodialysis. Ren Fail. 2010, 32: 21-26. 10.3109/08860220903375286.CrossRefPubMed Mistrik E, Dusilova Sulkova S, Blaha V, Kalousova M, Knizek J, Moucka P, Herout V, Kadlec M, Stilec R, Sobotka L: Evaluation of skin microcirculation during hemodialysis. Ren Fail. 2010, 32: 21-26. 10.3109/08860220903375286.CrossRefPubMed
19.
go back to reference Weiss T, Windthorst C, Weiss C, Kreuzer J, Bommer J, Kubler W: Acute effects of haemodialysis on cutaneous microcirculation in patients with peripheral arterial occlusive disease. Nephrol Dial Transplant. 1998, 13: 2317-2321. 10.1093/ndt/13.9.2317.CrossRefPubMed Weiss T, Windthorst C, Weiss C, Kreuzer J, Bommer J, Kubler W: Acute effects of haemodialysis on cutaneous microcirculation in patients with peripheral arterial occlusive disease. Nephrol Dial Transplant. 1998, 13: 2317-2321. 10.1093/ndt/13.9.2317.CrossRefPubMed
20.
go back to reference Megerman J, Mihelakos PT, Katsamouris AN, Fahmy NR, Lappas DG, Abbott WM: Continuous monitoring of oxygen tension with a transcutaneous sensor during hypotensive anesthesia. Acta Anaesthesiol Scand. 1987, 31: 25-29.CrossRefPubMed Megerman J, Mihelakos PT, Katsamouris AN, Fahmy NR, Lappas DG, Abbott WM: Continuous monitoring of oxygen tension with a transcutaneous sensor during hypotensive anesthesia. Acta Anaesthesiol Scand. 1987, 31: 25-29.CrossRefPubMed
21.
go back to reference Kanoore Edul VS, Dubin A, Ince C: The microcirculation as a therapeutic target in the treatment of sepsis and shock. Semin Respir Crit Care Med. 2011, 32: 558-568. 10.1055/s-0031-1287864.CrossRefPubMed Kanoore Edul VS, Dubin A, Ince C: The microcirculation as a therapeutic target in the treatment of sepsis and shock. Semin Respir Crit Care Med. 2011, 32: 558-568. 10.1055/s-0031-1287864.CrossRefPubMed
22.
go back to reference Sair M, Etherington PJ, Peter Winlove C, Evans TW: Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med. 2001, 29: 1343-1349. 10.1097/00003246-200107000-00008.CrossRefPubMed Sair M, Etherington PJ, Peter Winlove C, Evans TW: Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med. 2001, 29: 1343-1349. 10.1097/00003246-200107000-00008.CrossRefPubMed
23.
go back to reference Ligtenberg G, Barnas MG, Koomans HA: Intradialytic hypotension: new insights into the mechanism of vasovagal syncope. Nephrol Dial Transplant. 1998, 13: 2745-2747. 10.1093/ndt/13.11.2745.CrossRefPubMed Ligtenberg G, Barnas MG, Koomans HA: Intradialytic hypotension: new insights into the mechanism of vasovagal syncope. Nephrol Dial Transplant. 1998, 13: 2745-2747. 10.1093/ndt/13.11.2745.CrossRefPubMed
24.
go back to reference Beckert S, Sundermann K, Wolf S, Konigsrainer A, Coerper S: Haemodialysis is associated with changes in cutaneous microcirculation in diabetes mellitus. Diabet Med. 2009, 26: 89-92. 10.1111/j.1464-5491.2008.02610.x.CrossRefPubMed Beckert S, Sundermann K, Wolf S, Konigsrainer A, Coerper S: Haemodialysis is associated with changes in cutaneous microcirculation in diabetes mellitus. Diabet Med. 2009, 26: 89-92. 10.1111/j.1464-5491.2008.02610.x.CrossRefPubMed
25.
go back to reference Deruddre S, Pottecher J, Georger J: Sublingual microcirculatory improvement with fluid loading in preload-dependent ICU patients. Intensive Care Med. 2007, 33: S253-CrossRef Deruddre S, Pottecher J, Georger J: Sublingual microcirculatory improvement with fluid loading in preload-dependent ICU patients. Intensive Care Med. 2007, 33: S253-CrossRef
26.
go back to reference Hinchliffe RJ, Kirk B, Bhattacharjee D, Roe S, Jeffcoate W, Game F: The effect of haemodialysis on transcutaneous oxygen tension in patients with diabetes-a pilot study. Nephrol Dial Transplant. 2006, 21: 1981-1983. 10.1093/ndt/gfl241.CrossRefPubMed Hinchliffe RJ, Kirk B, Bhattacharjee D, Roe S, Jeffcoate W, Game F: The effect of haemodialysis on transcutaneous oxygen tension in patients with diabetes-a pilot study. Nephrol Dial Transplant. 2006, 21: 1981-1983. 10.1093/ndt/gfl241.CrossRefPubMed
27.
go back to reference Santoro A, Mancini E, Basile C, Amoroso L, Di Giulio S, Usberti M, Colasanti G, Verzetti G, Rocco A, Imbasciati E, Panzetta G, Bolzani R, Grandi F, Polacchini M: Blood volume controlled hemodialysis in hypotensione-prone patients: a randomized multicenter controlled trial. Kidney Int. 2002, 62: 1034-1045. 10.1046/j.1523-1755.2002.00511.x.CrossRefPubMed Santoro A, Mancini E, Basile C, Amoroso L, Di Giulio S, Usberti M, Colasanti G, Verzetti G, Rocco A, Imbasciati E, Panzetta G, Bolzani R, Grandi F, Polacchini M: Blood volume controlled hemodialysis in hypotensione-prone patients: a randomized multicenter controlled trial. Kidney Int. 2002, 62: 1034-1045. 10.1046/j.1523-1755.2002.00511.x.CrossRefPubMed
28.
go back to reference Van der Sande FM, Luik AJ, Kooman JP, Verstappen V, Leunissen KM: Effect of intravenous fluids on blood pressure course during hemodialysis in hypotensive-prone patients. J Am Soc Nephrol. 2000, 11: 550-555.PubMed Van der Sande FM, Luik AJ, Kooman JP, Verstappen V, Leunissen KM: Effect of intravenous fluids on blood pressure course during hemodialysis in hypotensive-prone patients. J Am Soc Nephrol. 2000, 11: 550-555.PubMed
29.
go back to reference Eltzschig HK, Eckle T: Ischemia and reperfusion–from mechanism to translation. Nat Med. 2011, 17: 1391-1401. 10.1038/nm.2507.CrossRefPubMed Eltzschig HK, Eckle T: Ischemia and reperfusion–from mechanism to translation. Nat Med. 2011, 17: 1391-1401. 10.1038/nm.2507.CrossRefPubMed
30.
go back to reference Del Vecchio L, Locatelli F, Carini M: What we know about oxidative stress in patients with chronic kidney disease on dialysis–clinical effects, potential treatment, and prevention. Semin Dial. 2011, 24: 56-64. 10.1111/j.1525-139X.2010.00819.x.CrossRefPubMed Del Vecchio L, Locatelli F, Carini M: What we know about oxidative stress in patients with chronic kidney disease on dialysis–clinical effects, potential treatment, and prevention. Semin Dial. 2011, 24: 56-64. 10.1111/j.1525-139X.2010.00819.x.CrossRefPubMed
31.
go back to reference Mizuno Y, Jacob RF, Mason RP: Inflammation and the development of atherosclerosis. J Atheroscler Thromb. 2011, 18: 351-358. 10.5551/jat.7591.CrossRefPubMed Mizuno Y, Jacob RF, Mason RP: Inflammation and the development of atherosclerosis. J Atheroscler Thromb. 2011, 18: 351-358. 10.5551/jat.7591.CrossRefPubMed
32.
go back to reference O’Hare AM, Sidawy AN, Feinglass J, Merine KM, Daley J, Khuri S, Henderson WG, Johansen KL: Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg. 2004, 39: 709-716. 10.1016/j.jvs.2003.11.038.CrossRefPubMed O’Hare AM, Sidawy AN, Feinglass J, Merine KM, Daley J, Khuri S, Henderson WG, Johansen KL: Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg. 2004, 39: 709-716. 10.1016/j.jvs.2003.11.038.CrossRefPubMed
33.
go back to reference Teatini U, Ballerini L, Romei Longhena G, Savino R, Maltagliati L, Masi F, Colombo R, Cimino R, Manfredi A: Microcirculation as a novel marker of membrane biocompatibility. Int J Artif Organs. 2006, 29: 1117-1120.PubMed Teatini U, Ballerini L, Romei Longhena G, Savino R, Maltagliati L, Masi F, Colombo R, Cimino R, Manfredi A: Microcirculation as a novel marker of membrane biocompatibility. Int J Artif Organs. 2006, 29: 1117-1120.PubMed
Metadata
Title
Detection of microcirculatory impairment by transcutaneous oxymetry monitoring during hemodialysis: an observational study
Authors
Ygal Benhamou
Loic Begarin
Nathalie David
Nicole Cailleux
Catherine Bessin
Herve Lévesque
Stephane Edet
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-4

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.